Back to results
US 7,067,493 B2Granted
Single dose azithromycin
AssigneePfizer Inc.
InventorMichael W. Dunne
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method of treating infections in humans by administering a single dose of azithromycin.
Claims18
A method of treating an acute otitis media infection in a human comprising administering to a human in need thereof a single dose of azithromycin wherein the dose is between about 30 mg/kg and about 90 mg/kg body weight;
- wherein the acute otitis media is caused by an S. pneumoniae isolate containing a mef A gene.
A method of treating acute otitis media in a human comprising administering to a human in need thereof a single dose of azithromycin wherein the dose is within the range of about 1.5 to 4.5 g;
- wherein the acute otitis media is caused by an S. pneumoniae isolate containing a mef A gene.
Dependencies are inferred from the claim text.